Imperial College London

Dr. Ramzi Y Khamis MB ChB PhD FESC FRCP

Faculty of MedicineNational Heart & Lung Institute

Reader in Cardiology
 
 
 
//

Contact

 

+44 (0)20 7594 6842r.khamis

 
 
//

Location

 

ICTEM buildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Hartley:2019:10.1016/j.tcm.2018.05.010,
author = {Hartley, A and Dorian, H and Khamis, RYJ},
doi = {10.1016/j.tcm.2018.05.010},
journal = {Trends in Cardiovascular Medicine},
pages = {22--26},
title = {Oxidized LDL and anti-oxidized LDL antibodies in atherosclerosis - novel insights and future directions in diagnosis and therapy},
url = {http://dx.doi.org/10.1016/j.tcm.2018.05.010},
volume = {29},
year = {2019}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - We provide an up-to-date overview of current topics surrounding oxidized low-density lipoprotein (oxLDL) and its related antibodies in the quest to better identify the individuals at risk of cardiovascular disease and atherosclerotic plaques with unfavorable characteristics. We discuss the potential of oxLDL and anti-oxLDL antibodies as serum biomarkers of cardiovascular disease and emerging studies examining the targeting of arterial oxLDL for imaging and therapeutic delivery.
AU - Hartley,A
AU - Dorian,H
AU - Khamis,RYJ
DO - 10.1016/j.tcm.2018.05.010
EP - 26
PY - 2019///
SN - 1050-1738
SP - 22
TI - Oxidized LDL and anti-oxidized LDL antibodies in atherosclerosis - novel insights and future directions in diagnosis and therapy
T2 - Trends in Cardiovascular Medicine
UR - http://dx.doi.org/10.1016/j.tcm.2018.05.010
UR - https://www.sciencedirect.com/science/article/pii/S1050173818300835?via%3Dihub
UR - http://hdl.handle.net/10044/1/60374
VL - 29
ER -